Corgentech (CGTK) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Corgentech (CGTK)

An SI Board Since April 2004

Posts	SubjectMarks	Bans	Symbol
39	11	0	CGTK

Emcee: michael_f_murphy	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
39	>>Anesiva to Host Webcast Conference Call on Monday, January 8, 2007 to Re	tuck	-	1/5/2007
38	Corgentech Pain Drug, 4975, Demonstrates Statistically Significant Pain Reductio	LJM	-	6/15/2006
37	>>All patients in both the treatment and placebo arms received paracetamol	tuck	-	3/24/2006
36	Corgentech Reports Phase 2 Trial Results for 4975 in Hernia Repair Pain Friday M	nigel bates	-	3/24/2006
35	Corgentech Presents Clinical Data From Phase 1/2 Trial of Avrina(TM), Drug Candi	nigel bates	-	3/6/2006
34	jci.org Full-text freebie. Can't remember if the authors have CGTK affil	tuck	-	11/3/2005
33	I'm accumulating based on gaps at much higher levels, and more importantly,	Gary105	-	6/27/2005
32	>>SOUTH SAN FRANCISCO, Calif., May 24 /PRNewswire-FirstCall/ -- Corgentech	tuck	-	5/24/2005
31	Corgentech and Bristol-Myers Squibb Announce Results From Edifoligide (E2F Decoy	nigel bates	-	3/30/2005
30	<<<<So we haven't reached fair value yet... ?>>>> U	rkrw	-	12/6/2004
29	So we haven't reached fair value yet... ? (Always tempted to bottom fish, b	nigel bates	-	12/6/2004
28	CC sounded to me like the decoy did no better than placebo, no trends, a complet	rkrw	-	12/6/2004
27	Corgentech and Bristol-Myers Squibb Announce Results From Edifoligide (E2F Decoy	nigel bates	-	12/6/2004
26	>>SOUTH SAN FRANCISCO, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Corgentech	tuck	-	12/3/2004
25	Baseline info for PREVENT III trial (thanks to Yahoo poster ThurstonHowellTheThi	tuck	-	12/3/2004
24	Tuck, Thanks for filling me in on the p2 trial for av fistulas in hemodialysis.	Archie Meeties	-	11/21/2004
23	CGTK is involved with all three. PIII for the PBG and CABG indications, and PI/	tuck	-	11/18/2004
22	Thank you Archimedes. Would like to think I could give you an informed answer t	keokalani'nui	-	11/18/2004
21	You know an awful lot for a zamboni driver :-)	rkrw	-	11/18/2004
20	Wilder, An ambitious idea, and as they said, one that's failed many times b	Archie Meeties	-	11/18/2004
19	Archimedes, Sorry to hit you with a question, but now you've revealed yours	keokalani'nui	-	11/18/2004
18	Hey Tuck, <i>I can find precious little info about the methodology being	SnowShredder	-	11/18/2004
17	We're talking about three different procedures, two of which CGTK is involve	Archie Meeties	-	11/18/2004
16	It's unclear to me how they're dealing with this in the trials for arter	tuck	-	11/18/2004
15	Tuck, I've been thinking about another, larger market for an e2f inhibitor	Archie Meeties	-	11/18/2004

Go to reply# or date (mm/dd/yy):